Canon proudly announces extention to its digital retinal camera with the CR-2 Plus

CR-2 Plus Non-Myd retinal camera with Fundus Autofluorescence (FAF) capabilities
CR-2 Non-Mydriatic retinal camera with fundus autofluorescence (FAF) capabilities

Canon, world-leader in imaging solutions has announced the introduction of the new CR-2 Plus, a non-Mydriatic camera with Fundus Autofluorescence (FAF) capabilities. Incorporating Canon EOS digital SLR technology, this high-end Non-Mydriatic Retinal Camera has a unique 18 - megapixel digital camera adapted specifically for ophthalmic photography. This dedicated camera with EOS technology was specifically developed for Canon's retinal cameras. This unique camera has been created for optimal retinal imaging and allows the CR-2 Plus to offer the best possible image quality, whilst remaining compact and lightweight for ease of handling

FAF imaging for the diagnosis of retinal disease is a relatively new diagnostic technique that provides more information on the health of the retinal pigment epithelium. It has become increasingly popular due to its non-invasive nature.

The CR-2 Plus works with the widest range of ISO settings so that the eye care professionals can choose to use very low ISO speeds to attain the best possible image without compromising on quality. The low flash mode in combination with higher ISO values will not cause the pupil to constrict after flash, meaning images can be taken in quick succession.

The CR-2 Plus comes complete with software optimised workflow and provides the option to seamlessly connect to hospital networks and practice management systems and is fully DICOM compliant.

 
 

Latest News

Subscribe via RSS Syndicate content

dio-banner.jpg

Events

  • 27 January, 2012 - 30 June, 2012

    Ophthalmic Laser Study Day 2012

    Carleton Optical in association with IRIDEX are pleased to announce plans for an ophthalmic laser awareness study day.

    Subjects to be covered will include innovative treatments for diabetic retinopathy, an update on transcleral cyclophotocoagulation and a review of the IQ 577nm Yellow Laser. Whilst timings are yet to be confirmed, it will be a London venue probably in the second half of July 2012.